medigraphic.com
ENGLISH

Revista Cubana de Plantas Medicinales

ISSN 1028-4796 (Impreso)
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2016, Número 4

<< Anterior Siguiente >>

Rev Cubana Plant Med 2016; 21 (4)


Efecto inhibitorio de extractos de corteza de Persea cordata Mez. (pau-andrade) contra Clostridium perfringens causa de mastitis gangrenosa

Schlemper V, de Mello SSR, Sousa MDM
Texto completo Cómo citar este artículo Artículos similares

Idioma: Ingles.
Referencias bibliográficas: 56
Paginas: 1-14
Archivo PDF: 172.27 Kb.


PALABRAS CLAVE

plantas medicinales, Persea cordata, antimicrobiano, Clostridium perfringens, mastitis.

RESUMEN

Introducción: la mastitis gangrenosa es una presentación clínica especial de mastitis en el ganado y pequeños rumiantes. Persea cordata Mez., es un árbol conocido en la etnoveterinaria brasileña, cuya corteza se utiliza en la curación de heridas en animales de granja.
Objetivos: investigar el efecto antimicrobiano in vitro de fracciones apolares de la corteza de P. cordata contra una cepa salvaje de C. perfringens, aislada de la ubre de una vaca con mastitis gangrenosa y una cepa de referencia.
Métodos: Se recogió una muestra de leche de la ubre, se diluyeron alícuotas, y se realizaron frotis teñidos por Gram. Las alícuotas fueron inoculadas en caldo y sembradas en agar sangre, y posteriormente incubados en anaerobiosis a 37 oC/24h. La identificación bioquímica fue realizada a partir del aislamiento bacteriano. La actividad inhibitoria in vitro de las fracciones apolares de P. cordata fue evaluada utilizando la técnica de difusión en agar y la CMI (concentración minima inhibitoria) mediante el método de dilución en agar.
Resultados: los extractos de la planta, en ambas pruebas, presentaron significativa actividad inhibitoria in vitro contra las cepas clínica y de referencia de C. perfringens ensayadas.
Conclusión: se concluyó que, por primera vez, se demuestra un efecto inhibitorio de P. cordata sobre C. perfringens, reforzando el uso popular, debido a sus propiedades antimicrobianas. Los extractos podrán ser utilizados como coadyuvantes en el tratamiento de la mastitis gangrenosa.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Watts JL. Etiological agents of bovine mastitis. Vet Microbiol. 1988;16(1):41-66. http://ac.els-cdn.com/0378113588901265/1-s2.0-0378113588901265-main. pdf?tid=c4c1af1e-5731-11e5-ac2b-00000aab0f27&acdnat=1441830877 771e 34a 6b39f6082c9e5301a771e251f

  2. Schalm OW, Carrol EJ, Jain NC. Origin, development and evolution of the mammary glands. In: Idem Bovine Mastitis. 1st ed., Philadelphia: Lea and Febiger; 1971.

  3. Renk W. Etiology, pathogenesis and morphology of bovine mastitis. Vet Med Review. 1967;1:3-21. http://www.scielo.br/scielo.php?script=scinlinks&ref= 0000 51&pid=S0103-8478200600040004900011&lng=es

  4. Giesecke WH, Tustin RC, Malan C. Bovine mastitis due to Clostridium perfringens type A and Bacillus cereus. J South Afr Vet Assoc. 1969;40(4):342. http://www.scielo.br/scielo.php?script=sci_nlinks&ref=000046&pid=S0103-8478 200600040004900006&lng=en

  5. Johnston AM. A successfully treated case of mastitis in the bovine associated with Clostridium perfringens type A. Vet Rec. 1986;118(26):728-9. http:// www.ncbi.nlm.nih.gov/pubmed/2426858

  6. Bergonier D, De Crémoux R, Rupp R, Lagriffoul J, Berthelot X. Mastitis of dairy small ruminants. Vet Res. 2003;34(5):689-16. http://www.vetres.org/articles/ vetres/pdf/2003/05/V3511.pdf

  7. Ribeiro MG, Lara GHB, Bicudo SD, Souza AVG, Salerno T, Siqueira AK, et al. An unusual gangrenous goat mastitis caused byStaphylococcus aureus, Clostridium perfringens and Escherichia coli co-infection. Arq Bras Med Vet Zootec. 2007;59(3):810-2. http://www.scielo.br/pdf/abmvz/v59n3/a37 v59n3.pdf

  8. Quinn PJ, Markey BK, Leonard FC, Fitzpatrick ES, Fanning S, Hartigan PJ. Veterinary microbiology and microbial disease 2th ed., West Sussex: Wiley-Blackwell; 2011.

  9. Baldassi L, Calil EMB, Portugal MASC. Mastite gangrenosa bovina causada por agentes do gênero Clostridium. Arq Inst Biol. 1995;62(1-2),15-20. http://www.fmvz.unesp.br/rvz/index.php/rvz/article/download/452/345

  10. Gonçalves LA, Freitas TD, Assis RA, Facury-Filho EJ, Lobato FCF. Primeiro relato no Brasil de mastite necrótica bovina por Clostridium perfringens tipo A. Cienc Rural. 2006;36(4):1331-3. http://www.scielo.br/pdf/cr/v36n4/a49v36 n4.pdf

  11. Costa EO, Coutinho SD, Castilho W, Teixeira CM, Gambale W, Gandra CRP. Etiologia bacteriana da mastite bovina, no Estado de São Paulo, Brasil. Rev Microbiol. 1986;17(2):107-12. http://bases.bireme.br/cgi-bin/wxislind.exe/iah/ online/?IsisScript=iah/iah.xis&nextAction=lnk&base=LILACS&exprSearch=57584&ind exSearch=ID&lang=p

  12. Du Preez JH. The role of anaerobic bacteria in bovine mastitis: a review. J South Afr Vet Assoc. 1989;60(3):159-68. http://www.ncbi.nlm.nih.gov/pub med/2699500

  13. Niilo L. Clostridium perfringens in animal disease: a review of current knowledge. Can Vet J. 1980;21(5):141-8. http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC1789702/

  14. Mallard BA, Dekkers JC, Ireland MJ, Leslie KE, Sharif S, Vankampen C L, Wagter L, Wilkie BN. Alteration in immune responsiveness during the peripartum period and its ramification on dairy cow and calf health. J Dairy Sci., 1998;81(2):585-95. http://www.sciencedirect.com/science/article/pii/S0022030298756127

  15. Rood JI, McClane BA, Songer JG, Titball RW. The clostridia: molecular biology and pathogenesis. 1st ed., San Diego: Academic Press; 1997.

  16. Corrêa MP. Dicionário das plantas úteis do Brasil e das exóticas cultivadas. 3th ed. Rio de Janeiro: IBDF/MA; 1984.

  17. Schlemper SRM, Schlemper V, Da Silva D, Cordeiro F, Cruz AB, Oliveira E, Cechinel Filho V. Antibacterial activity of Persea cordata stem barks. Fitoterapia, 2001;72(1):73-5. http://www.sciencedirect.com/science/article/pii/S0367326X 00002550

  18. Schlemper, V., Schlemper, S.R., Zampirolo, J.A. 2013. Antiedematogenic effects of the polar fractions of Persea cordata Mez. (Lauraceae) on microvascular extravasation in rat skin. J. Ethnopharmacol., 150;244-51. http://www.ncbi.nlm.nih.gov/pubmed/23993911

  19. Schlemper SRM, Silva D, Cechinel-Filho V, Floriani AE. Avaliação da atividade antimicrobiana de extratos de plantas da flora catarinense: Persea cordata (Laureacea) e Alternanthera brasiliana (Amaranthaceae). Alcance. 1998;2(5):31-5.

  20. Cechinel Filho V, Zampirolo JA, Stulzer HK, Schlemper V. Antispasmodic effects of Persea cordata bark fractions on guinea pig ileum. Fitoterapia. 2007;78(2):125-8. http://www.ncbi.nlm.nih.gov/pubmed/17174038

  21. Zampirolo JA, Stulzer HK, Tagliari MP, Schlemper V, Cechinel Filho V.Antispasmodic Activity of Persea cordata Vell. Mez. (Lauraceae) Fractions on Guinea Pig Ileum Induced by 5-Hydroxytryptamine and Bradykinin. American. J Pharmacol Toxicol., 2008;3(4):229-33. http://thescipub.com/PDF/ajptsp. 2008.229.233.pdf

  22. Fedalto ML, Ludka FK, Tasca CI, Molz S. Neuroprotection of Persea major extract against oxygen and glucose deprivation in hippocampal slice involves increased glutamate uptake and modulation of A1 and A2A adenosine receptors. Rev Bras Farmacogn. 2013;23(5):789-95. http://www.scielo.br/pdf/ rbfar/v23n5/0102-695xrbfar- 23-05-0789.pdf

  23. Vieira SC, Krause GA, Zampirolo JA, Lucinda RM, Schlemper V, Schlemper SRM. Efeito cicatrizante da pomada de Persea cordata Mez. (Lauraceae) em feridas cutâneas de cobaias. Rev Bras Pl Med. 2001;3(2):31-5. http://www.sbpmed.org.br/download/issn_01/artigo_6_v3_n2.pdf

  24. Marini-Bettólo GB, Nicoletti M, Patamia M, Galeffi C, Messana I. Plant screening by chemical and chromatographic procedures under field conditions. J Chromatogr. 1981;213(1):113-27. http://www.sciencedirect.com/science/ article/pii/S0021967300806391

  25. Harborne JB. Phytochemical methods: a guide to modern techniques of plant analysis. 2nd ed., London-New York: Chapman and Hall; 1984.

  26. Cato EP, George WL, Finegold SM. Genus Clostridium. In: Sneath, P.H.A. (1st Ed.) Bergey's Manual of Systematic Bacteriology. Baltimore: Willians and Wilkins; 1986. p. 1141-1200.

  27. Rhodehame J, Harmon SM. Clostridium perfringens. In: Bennet, R. W. (8th Ed.), FDA Bacteriological Manual, Gaithersburg: AOAC International; 1998. p. 16.01-16.06.

  28. Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4):493-6. http://www.ncbi.nlm.nih.gov/pubmed/5325707

  29. Cavalieri SJ, Harbeck RJ, McCarter YS, Ortez JH, Rankin ID, Sautter RL, Sharp SE, Spiegel CA. Manual of antimicrobial susceptibility testing. Washington DC: American Society for Microbiology; 2005.

  30. Daguet, G.I., Chabbert, Y.A. 1977. (1st Ed.), Serología bacteriana. Antibióticos en bacteriología médica. In: Técnicas en bacteriología III, Jims, Barcelona.

  31. Costa GM, Assis RA, Lobato SCF. Diarréia em leitões lactentes por Clostridium perfringens tipo A em granjas tecnificadas nos Estados de Minas Gerais e São Paulo. Arq Bras Med Vet Zootec. 2004;56(3):401-4. http://www.scielo.br/pdf/abmvz/v56n3/v56n3a18.pdf

  32. Siragusa GR, Haas GJ, Matthews PD, Smith RJ, Buhr RJ, Dale NM, Wise MG. Antimicrobial activity of lupulone against Clostridium perfringens in the chicken intestinal tract jejunum and caecum. J Antimicrob Chemother. 2008;61(4):853-8. http://jac.oxfordjournals.org/content/61/4/853.short

  33. Savic B, Prodanovic R, Ivetic V, Radanovic O, Bojkovski J. Enteritis associated with Clostridium perfringens type A in 9-month-old calves. Can Vet J. 2012;53(2):174-6. http://www.ncbi.nlm.nih.gov/pubmed/22851779

  34. Maboni F, Skorei MR, Rocha RX, Vargas AC, Cecim M. Mastite gangrenosa bovina por Clostridium perfringens. Vet Zootec. 2008;15(3):456-9. http://www.fmvz.unesp.br/rvz/index.php/rvz/article/view/452

  35. Silva NCC, Fernades Júnior A. Biological properties of medicinal plants: a review of their antimicrobial activity. J Venom Anim Toxins Include Trop Dis. 2010;16(3):402-13. http://www.scielo.br/pdf/jvatitd/v16n3/a06v16n3.pdf

  36. Livermore DM. Discovery research: the scientific challenge of finding new antibiotics. J Antimicrob Chemother. 2011;66(9):1941-4. http://jac. Oxfordjour nals.org/content/early/2011/06/22/jac.dkr262.full.pdf+html

  37. Goel A, Sharma K. Plant extracts and phytochemicals as herbal medicines and antimicrobials. Int J Biol Med Res. 2014;5(1): 3940-6. http://www.biomedscidirect.com/journalfiles/IJBMRF20131443/plant_extracts_and_p hytochemicals_as_herbal_medicines_and_antimicrobials.pdf

  38. Ahn Y-J, Lee C-O, Kweon J-H, Ahn J-W, Park J-H. Growth-inhibitory effects of Galla rhois-derived tannins on intestinal bacteria. J Appl Microbiol. 1998;84(3):439- 443. http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2672.1998.003 63.x/epdf

  39. Lee H-S, Beon M-S, Kim M-K. Selective Growth Inhibitor toward Human Intestinal Bacteria Derived from Pulsatilla cernua root. J Agric Food Chem. 2001;49(10):4656- 4661. http://pubs.acs.org/doi/abs/10.1021/jf010609z

  40. Larson TR. Screening various plant and and fungal extracts against Clostridium perfringens for antimicrobial activity. UW-L J Undergrad Res. 2007;X:1-3. http://www.uwlax.edu/urc/JUR-online/PDF/2007/larson.pdf

  41. Dzomba P, Muchanyereyi N. Potential antimicrobial plant extract based therapeutics from Temnocalyx obovatus roots. Eur J Med Plants. 2012;2(3):209-15. DOI:10.9734/EJMP/2012/1293

  42. Gadhi CA, Weber M, Mory F, Benharref A, Lion C, Jana M, Lozniewski A. Antibacterial activity of Aristolochia paucinervis Pomel. J Ethnopharmacol. 1999;67(1):87-92. http://digilib.buse.ac.zw:8090/xmlui/bitstream/handle/11196/595/ Potential%20antimicrobial%20dzomba.pdf?sequence=1

  43. Lee H-S, Beon M-S, Kim M-K. Selective Growth Inhibitor toward Human Intestinal Bacteria Derived from Pulsatilla cernua Root. J Agric Food Chem. 2001;49(10):4656- 61. http://pubs.acs.org/doi/pdf/10.1021/jf010609z

  44. Bona TDMM, Pickler L, Miglino LB, Kuritza LN, Vasconcelos SP, Santin E. Óleo essencial de orégano, alecrim, canela e extrato de pimenta no controle de Salmonella, Eimeria e Clostridium em frangos de corte. Pesq Vet Bras. 2012;32(5):411-8. http://www.scielo.br/pdf/pvb/v32n5/a09v32n5.pdf

  45. Bento MHL, Ouwehand AC, Tiihonen K, Lahtinen S, Nurminen P., Saarinen MT, Schulze H, Mygind T, Fischer J. Essential oils and their use in animal feeds for monogastric animals-effects on feed quality, gut microbiota, growth performance and food safety: a review. Vet Med. 2013;58(9):449-58. http://vri.cz/docs/vetmed/58-9- 449.pdf

  46. Jimoh AA, Ibitoye EB, Dabay YU, Garba S. In vivo antimicrobial potentials of garlic against Clostridium perfringens and its promotant effects on performance of broilers chickens. Pak J Biol Sci. 2013;16(24):1978-84. http://www.ncbi. nlm.nih.gov/pubmed/24517015

  47. Gibbons S. Plants as a source of bacterial resistance modulators and anti-infective agents. Phytochem Rev. 2005;4(1):63-78. http://link.springer.com/ article/10.1007%2Fs11101-005-2494-9

  48. Aligiannis N, Kalpoutzakis E, Mitaku S, Chinou IB. Composition and antimicrobial activity of the essential oil of two Origanum species. J Agric Food Chem. 2001;49(9):4168-70. http://pubs.acs.org/doi/abs/10.1021/ jf001494m? journalCode=jafcau

  49. Duarte MCT, Figueira GM, Sartoratto A, Rehder VL, Delarmelina C. Anti-Candida activity of Brazilian medicinal plants. J Ethnopharmacol. 2005;97(2):305-11. http://www.sciencedirect.com/science/article/pii/S0378874104005781

  50. Sieben PG. Composição fitoquímica de cascas de Persea major (MEISN.) L. E. KOPP (Lauraceae), desenvolvimento e avaliação preliminar de formas farmacêuticas para uso tópico. [Master´s dissertation]. Curitiba(PR): Universidade Federal do Paraná. 2012. Portuguese. http://dspace.c3sl.ufpr.br/dspace/bitstream/ handle/1884/28368/R%

  51. Miranda RRS, Silva GDF, Duarte LP, Fortes ICP, Viera-Filho SA. Structural determination of 3β-stearyloxy-urs-12-ene from Maytenus salicifolia by 1D and 2D NMR and quantitative 13C NMR spectroscopy. Magn Res Chem. 2006;44(2):127-31. http://onlinelibrary.wiley.com/doi/10.1002/mrc.1734/pdf

  52. Ahameethunisa AR, Hopper W. In vitro antimicrobial activity on clinical microbial strains and antioxidant properties of Artemisia parviflora. Ann Clin Microbiol antimicrob. 2012;11(30):30-7. http://www.ann-clinmicrob.com/ content/pdf/1476- 0711-11-30.pdf

  53. Motlhanka D, Houghton P, Miljkovic-Brake A, Habtemarian S. A novel pentacyclic triterpene glycoside from a resin of Commiphora glandulosa from Botswana. Afr J Pharm Pharmacol. 2010;4(8):549-54. http://www.academicjournals.org/article/article1380785906_Motlhanka%20et%20al. pdf

  54. Dzomba P, Togarepi E, Musekiva WA. Phytochemicals antioxidant and antibacterial properties of a lichen species Cladonia digitata. Afr J Biotechnol. 2012;11(31):7995-9. http://www.ajol.info/index.php/ajb/article/view/103303/93 515

  55. El Deeb WM. Clinicobiochemical investigations of gangrenous mastitis in does: Immunological responses and oxidative stress biomarkers. J Zhejiang Univ Sci B. 2013;14(1):33-9. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC 3542956/pdf/JZUSB14-0033.pdf

  56. Fotou K, Tzora A, Voidarou CH, Alexopoulos A, Plessas S, Avgeris I, Bezirtzoglou E, Akrida-Deemertzi K, Demertzis PG. Isolation of microbial pathogens of subclinical mastitis from raw chip`s milk of Epirus (Greece) and their role in its hygiene. Anaer. 2011;17(6):315-9. http://www.sciencedirect.com/science/article/pii/S1075996411000837




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Plant Med. 2016;21

ARTíCULOS SIMILARES

CARGANDO ...